We chose to focus our further studies on the SUM159 line due to its rapid growth rate and near-diploid genome with limited copy-number alterations, and its origin as an invasive ductal carcinoma, as compared with SUM149 which was derived from a BRCA1-mutant inflammatory breast cancer. This evidence concerns the gene BRCA1 and invasive ductal breast carcinoma.